Section 503B of the FDCA (Drug Quality and Security Act of 2013) provides that a facility that compounds sterile drugs can elect to register with the FDA as an Outsourcing Facility (OF). Upon registering as an OF, the facility would be required to... Read More
Pharmacy Law